Squamous cell carcinomas of the head and neck (SCC-HN) make up about 90% of all head and neck cancers (HNC). They are malignant tumours arising in various regions including oral cavity, larynx (throat) and pharynx (comprised of three parts: nasopharynx, oropharynx, and laryngopharynx). It can also include cancer of the salivary glands, sinuses, muscles or nerves in the head and neck, but these types of cancer are much less common.
SCC-HN are the seventh most common cancer diagnosis worldwide. They can arise due to a variety of aetiologic factors including tobacco-exposure, alcohol consumption and high-risk human papilloma virus (HPV) infection. Clinical outcomes and treatments vary by anatomic site with 5-year survival rates ranging from 40-80% depending on stage, subsite, and HPV status (1).
At CancerTools.org, we have created an ever-growing collection of head and neck cancer research (HNC) tools, including patient-derived cell lines, which offer in vitro models for specific SCC-HN anatomical sites and antibodies for studying HNC biology.
Our collection also features antibodies to support HNC research, including those for HPV, as HPV status is a favourable indicator of prognosis in some subsets of HNC. As well as antibodies for p53 and EGFR, as overexpression of EGFR and inhibition of p53 are commonly observed in HPV-negative SCC-HN.